Skip to main content
Livermore
Livermore
ZHEN

Brown Advisory Inc

SEC CIK
0001345929
Latest filing
Aug 14, 2026

ASND holding history

Ascendis Pharma A/S in every 13F filed by Brown Advisory Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ASND overviewAll 13F holders of ASNDFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ASND by Brown Advisory Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−24,544−100.0%Sold outHolders
Q4 202524,544$5.23M<0.1%−789−3.1%ReducedHolders
Q3 202525,333$5.04M<0.1%−172−0.7%ReducedHolders
Q2 202525,505$4.40M<0.1%−355−1.4%ReducedHolders
Q1 202525,860$4.03M<0.1%−10,426−28.7%ReducedHolders
Q4 202436,286$5.00M<0.1%−431,366−92.2%ReducedHolders
Q3 2024467,652$69.8M0.1%−11,024−2.3%ReducedHolders
Q2 2024478,676$65.3M0.1%−205,396−30.0%ReducedHolders
Q1 2024684,072$103.4M0.1%+178,125+35.2%AddedHolders
Q4 2023505,947$63.7M0.1%−4,162−0.8%ReducedHolders
Q3 2023510,109$47.8M0.1%+13,227+2.7%AddedHolders
Q2 2023496,882$44.3M0.1%+30,510+6.5%AddedHolders
Q1 2023466,372$50.0M0.1%+26,080+5.9%AddedHolders
Q4 2022440,292$53.8M0.1%−197,709−31.0%ReducedHolders
Q3 2022638,001$65.9M0.1%−14,723−2.3%ReducedHolders
Q2 2022652,724$60.7M0.1%+133,112+25.6%AddedHolders
Q1 2022519,612$61.0M0.1%+43,458+9.1%AddedHolders
Q4 2021476,154$64.1M0.1%+54,927+13.0%AddedHolders
Q3 2021421,227$67.1M0.1%+8,816+2.1%AddedHolders
Q2 2021412,411$54.3M0.1%+109,989+36.4%AddedHolders
Q1 2021302,422$39.0M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.